Abstract:Introduction: Contrast-associated acute kidney injury (CA-AKI) is characterized as a loss of renal function following radiological contrast media administration. While all contrast media induce variable changes in microvascular endothelial cells in vitro, only few studies report clinical significance of their findings. A comprehensive assessment of the effect of iodinated contrast media on the renal function in vitro and in vivo is essential. The aim of our study was to morphometrically quantify the effect of two different contrast media (Iobitridol and Iodixanol) on vascular endothelial capillaries in vitro and to analyze their effect on the renal function of patients who underwent cardiac catheterization including the intra-arterial administration of contrast media, by measuring serum creatinine concentration (SCr), a byproduct of muscle metabolism, primarily excreted by the kidneys. Our hypothesis suggests that conducting a qualitative comparison of both outcomes will enable identification of differences and similarities between in vitro and in vivo exposure. Material and methods: In vitro, co-cultures of human dermal fibroblasts and human dermal microvascular endothelial cells forming capillary beds were exposed to a mixture of phosphate buffered saline and either Iobitridol, Iodixanol, or one of their supplements EDTA or Trometamol for 1.5 or 5 min. Negative control co-cultures were exposed exclusively to phosphate buffered saline. Co-cultures were either directly fixed or underwent a regeneration time of 1, 3 or 7 days. An artificial intelligence software was trained for detection of labeled endothelial capillaries (CD31) on light microscope images and measurements of morphometric parameters. In vivo, we retrospectively analyzed data from patients who underwent intra-arterial administration of contrast media and for whom SCr values were available pre- and post-contrast exposition (1, 3, and 7 days following procedure). Temporal development of SCr and incidence of CA-AKI were assessed. Both exposure types were qualitatively compared. Results: In vitro, Iobitridol, Iodixanol and EDTA induced a strong decrease of two morphometric parameters after 3 days of regeneration. In vivo, a significant increase of SCr and incidence of CA-AKI was observed 3 days following procedure in the post-contrast media patients. No difference was observed between groups. Discussion: Two of the morphometric parameters were inversely proportional to the SCr of the patients. If the endothelial damages observed in vitro occur in vivo, it may result in renal hypoxia, inducing a loss of kidney function clinically translated into an increase of SCr. Further development of our in vitro model could allow closer replication of the internal structure of a kidney and bridge the gap between in vitro studies and their clinical findings.

Differential Incidence of Contrast-Associated Acute Kidney Injury: Comparing Intravenous and Intraarterial Contrast Administration

Patients with Different Stages of Chronic Kidney Disease Undergoing Intravenous Contrast-Enhanced Computed Tomography—The Incidence of Contrast-Associated Acute Kidney Injury

Incidence of contrast-associated acute kidney injury: a prospective cohort

Current updates in radiocontrast-associated acute kidney injury

Prevention of contrast-associated acute kidney injury in an era of increasingly complex interventional procedures

Contrast-associated Acute Kidney Injury: an Update of Risk Factors, Risk Factor Scores, and Preventive Measures

Acute Kidney Injury in Patients with Nephrotic Syndrome Undergoing Contrast-Enhanced CT for Suspected Venous Thromboembolism: a Propensity Score-Matched Retrospective Cohort Study

Is Intravenous Contrast Associated with Increased Risk of Acute Kidney Injury?

Does safe dosing of iodinated contrast prevent contrast-induced acute kidney injury?

Contrast-induced Nephropathy in CT: Incidence, Risk Factors and Strategies for Prevention.

Erythrocyte Parameters, Anemia Conditions, and Sex Differences Are Associated with the Incidence of Contrast-Associated Acute Kidney Injury after Coronary Angiography.

Contrast medium induced acute kidney injury: a narrative review

Prevalence of Contrast-Induced Acute Kidney Injury in Acute Ischemic Stroke Patients Undergoing Contrast-Enhanced CT Angiography at a Tertiary Care Centre

Risk of Acute Kidney Injury with Consecutive, Multidose Use of Iodinated Contrast in Patients with Acute Ischemic Stroke

Acute Kidney Injury and Patients Undergoing Both Right and Left Heart Catheterization with Coronary Angiography Versus Right Heart Catheterization Only

Incidence And Risk Of Developing Contrast-Induced Acute Kidney Injury Following Intravascular Contrast Administration In Elderly Patients

Prevention of Contrast-Induced Acute Kidney Injury: an Update

Microvascular changes following exposure to iodinated contrast media in vitro. A qualitative comparison to serum creatinine concentrations in post-cardiac catheterization patients

Use of Intravenous Iodinated Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation

Cumulative Iodinated Contrast Exposure for Computed Tomography During Acute Kidney Injury and Major Adverse Kidney Events

Contrast Induced Acute Kidney Injury (CI- AKI) - Myths and Realities